Physician

Howard Schlossberg, M.D.

According to 2025 Medicare claims, Howard Schlossberg, M.D. (NPI: 1023005691) practices medical oncology in the Albany-Schenectady-Troy, NY market, with the plurality of this provider's patient population coming from Saratoga, NY. This provider's primary affiliated billing organization is NEW YORK ONCOLOGY HEMATOLOGY, P.C. (NPI: 1609863448; TIN: 141799724) and primary practice location at 12065-4172. Schlossberg is affiliated with the Adirondacks ACO, LLC (ACO ID: A2193) and Bassett Accountable Care Partners, LLC (ACO ID: A2612), participating under the MSSP model.

Schlossberg's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 798 traditional Medicare patients, billed 116,816 HCPCS/CPT codes, and received $1,924,935 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,378 prescription claims across 219 beneficiaries totaling $5,406,790 in drug costs, led by Imbruvica (Ibrutinib). 2021 DME data shows 93 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,398,619 to $5,406,790. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $2,388 to $1,795.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	700	97,151	$963,279
2016	824	123,851	$1,612,416
2017	795	102,042	$1,861,522
2018	813	126,716	$1,811,262
2019	805	139,669	$2,073,834
2020	770	151,486	$2,078,527
2021	812	155,249	$1,889,910
2022	820	122,815	$1,757,835
2023	764	103,494	$1,423,650
2024	798	116,816	$1,924,935

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	268	1,249	$1,398,619
2016	306	1,538	$2,300,948
2017	291	1,501	$3,265,384
2018	316	1,727	$3,484,946
2019	291	1,458	$3,427,420
2020	255	1,492	$4,778,858
2021	252	1,511	$6,154,028
2022	226	1,239	$4,840,231
2023	225	1,252	$5,464,883
2024	219	1,378	$5,406,790

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	18	$33,065
2016	22	88	$39,359
2017	24	80	$24,853
2018	N/R	126	$15,336
2019	N/R	196	$10,497
2020	N/R	227	$9,164
2021	N/R	93	$2,724
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	169	235	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	269	383	$62
80053	Blood test, comprehensive group of blood chemicals	302	627	$10
36415	Insertion of needle into vein for collection of blood sample	471	1,131	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	463	985	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	64	1,834	$818,262
Lenalidomide	Lenalidomide	79	2,025	$744,019
Ibrance	Palbociclib	47	1,316	$716,695
Calquence	Acalabrutinib Maleate	36	1,080	$540,025
Brukinsa	Zanubrutinib	33	990	$420,385

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Howard Schlossberg, M.D.?

Tedicare shows public-source Medicare data for Howard Schlossberg, M.D. (NPI 1023005691), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Howard Schlossberg, M.D. have ACO affiliation data?

Howard Schlossberg, M.D. is shown with ACO affiliation data for Adirondacks ACO, LLC (MSSP, ACO ID A2193) and Bassett Accountable Care Partners, LLC (MSSP, ACO ID A2612).

What billing organization is linked to Howard Schlossberg, M.D.?

Howard Schlossberg, M.D. is linked to NEW YORK ONCOLOGY HEMATOLOGY, P.C. (billing NPI 1609863448) in the available physician profile data.

Does Howard Schlossberg, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.